[在多发性髓瘤细胞中miR-383-5p的表达和临床意义]

Lin Liu1, Yan-Li Yang1, Feng Zhang1

  • 1Department of Hematology, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, Anhui Province, China.

概括

在多发性骨髓瘤 (MM) 患者中,microRNA-383-5p (miR-383-5p) 的下调. 低miR-383-5p表达表明预后不佳,并作为MM的潜在新生物标志物.